Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P; European Lacidipine Study on Atherosclerosis investigators. Zanchetti A, et al. Among authors: bond mg. Circulation. 2002 Nov 5;106(19):2422-7. doi: 10.1161/01.cir.0000039288.86470.dd. Circulation. 2002. PMID: 12417537 Clinical Trial.
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).
Zanchetti A, Bond MG, Hennig M, Tang R, Hollweck R, Mancia G, Eckes L, Micheli D; ELSA Investigators. Zanchetti A, et al. Among authors: bond mg. J Hypertens. 2004 Jun;22(6):1201-12. doi: 10.1097/00004872-200406000-00022. J Hypertens. 2004. PMID: 15167456 Clinical Trial.
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R. Zanchetti A, et al. Among authors: bond mg. J Hypertens. 1998 Jul;16(7):949-61. doi: 10.1097/00004872-199816070-00008. J Hypertens. 1998. PMID: 9794735 Clinical Trial.
Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Zanchetti A, Crepaldi G, Bond MG, Gallus G, Veglia F, Mancia G, Ventura A, Baggio G, Sampieri L, Rubba P, Sperti G, Magni A; PHYLLIS Investigators. Zanchetti A, et al. Among authors: bond mg. Stroke. 2004 Dec;35(12):2807-12. doi: 10.1161/01.STR.0000147041.00840.59. Epub 2004 Oct 28. Stroke. 2004. PMID: 15514192 Clinical Trial.
Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group.
Zanchetti A, Crepaldi G, Bond MG, Gallus GV, Veglia F, Ventura A, Mancia G, Baggio G, Sampieri L, Rubba P, Collatina S, Serrotti E. Zanchetti A, et al. Among authors: bond mg. J Hypertens. 2001 Jan;19(1):79-88. doi: 10.1097/00004872-200101000-00011. J Hypertens. 2001. PMID: 11204308 Clinical Trial.
150 results